
Tribose 0.3mg Tablet
Marketer
Ordain Health Care Global Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Tribose 0.3mg Tablet
Diabetease 0.3mg tablets manage type 2 diabetes mellitus by regulating postprandial hyperglycemia. This medication is prescribed when dietary modifications and other antidiabetic agents prove insufficient to control elevated blood glucose. Administer Diabetease 0.3mg immediately prior to meals; dosage and frequency are determined individually by your physician for optimal glycemic control. Discontinuation requires medical consultation to prevent potentially dangerous hyperglycemia, possibly leading to severe complications such as renal impairment and vision loss. Diabetease 0.3mg is a component of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include abdominal discomfort (gas, pain, loss of appetite), bowel irregularity (constipation or diarrhea). Report persistent or troublesome side effects to your physician. While Diabetease 0.3mg itself doesn't induce hypoglycemia, concomitant use with other antidiabetic medications (particularly insulin or sulfonylureas) increases this risk. Hypoglycemic episodes necessitate treatment with pure glucose; sucrose is ineffective. Prior to commencing treatment, inform your physician of any liver or kidney conditions. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. Comprehensive disclosure of all other medications is crucial for patient safety. Excessive alcohol consumption should be avoided due to the increased risk of hypoglycemia.
Uses of Tribose 0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Tribose 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tribose 0.3mg Tablet on an empty stomach.
Common Side effects of Tribose 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Tribose 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Tribose 0.3mg Tablet should be taken on an empty stomach.
How Tribose 0.3mg Tablet works:
Glimepiride 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Tribose 0.3mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of 0.3mg Tribose tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Tribose 0.3mg tablets without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Tribose 0.3mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Tribose 0.3mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Tribose 0.3mg tablets. Dosage modification for Tribose 0.3mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Tribose 0.3mg Tablet :
Omit any missed dose of Tribose 0.3mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Tribose 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
